findmyKOL

Joanne Mortimer, MD

Enriched profile

Baum Family Professor in Women's Cancers; Associate Director of Education and Training; Vice Chair and Professor, Department of Medical Oncology and Therapeutics Research; Director, Women's Cancer Programs · City of Hope National Medical Center

ORCIDNPI
Region🇺🇸 Duarte, CA · West · United StatesSpecialtyMedical OncologyFocusLymphoma+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2008–2026

Joanne Mortimer is Baum Family Professor in Women's Cancers; Associate Director of Education and Training; Vice Chair and Professor, Department of Medical Oncology and Therapeutics Research; Director, Women's Cancer Programs at City of Hope National Medical Center. OpenAlex indexes 475 publications with 18,461 citations (h-index 61); ClinicalTrials.gov lists 19 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Joanne Mortimer, MD, is Baum Family Professor in Women's Cancers at City of Hope National Medical Center, Duarte, CA. The public record shows 475 publications with 18,461 citations (h-index 61), centered on Lymphoma, Breast Cancer. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 10 companies, 3 NIH-funded awards (2008–2026).

  • Most recent indexed publication: 2026 · medRxiv
  • Top research focus: Lymphoma
  • 19 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer17 trialsInflammatory Breast Neoplasms2 trialsNeoplasm Metastasis1 trialLymphoma1 trialObesity1 trialCardiotoxicity1 trial

Research focus

OpenAlex concept fingerprint
LymphomaBreast Cancer

Drugs & molecules

across trials, industry payments and publications
Nerlynxgeneric · NeratinibClinical trialsIndustry payments2Publications1Kisqaligeneric · RibociclibClinical trialsIndustry payments15PublicationsEstradiolClinical trialsIndustry payments10Publications

Works with

trial sponsors and companies reporting payments
Novartis Pharmaceuticals CorporationClinical trialsIndustry payments17City of Hope Medical CenterClinical trials14Industry paymentsAstraZeneca Pharmaceuticals LPClinical trialsIndustry payments13

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
475publications

Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.

18,461citations

Total citations across indexed works.

61h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
19clinical trials

Investigator role on registered studies.

View trials
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 2008–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    84.9%
    Aromatase Inhibitor41.5%
    Anastrozole59%Letrozole41%
    Part D16 patients
    Kinase inhibitor36.5%
    Kisqali76%Ibrance24%
    Part D<11 patients
  • Nervous system

    15.1%
    gamma-Aminobutyric Acid A Receptor Positive Modulator8.2%
    Zolpidem Tartrate100%
    Part D<11 patients
    Phenothiazine6.9%
    Prochlorperazine Maleate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

3 NIH research awards on record, funded 20082026 per NIH RePORTER. The latest:

32 more award records behind the reveal.Reveal →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/joanne-mortimer-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Joanne-Mortimer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    talkwithaudrey.libsyn.com/dr-joanne-mortimer-medical-oncologist-at-city-of-hope-comprehensive-cancer-center-and-jessica-woman-diagnosed-with-breast-cancer-brca-mutation-and-importance-of-genetic-testing

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →talkwithaudrey.libsyn.com
  • Other

    ajmc.com/view/integrating-ctdna-into-breast-cancer-management-joanne-mortimer-md-facp-fasco

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com
  • Other

    cityofhope.org/research/comprehensive-cancer-center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cityofhope.org
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Hematology and Medical Oncology, Cleveland Clinic Foundation

    1982
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • Residency

    Internal Medicine, Cleveland Clinic Foundation

    1980
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • MD

    Loyola University Stritch School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cityofhope.org
  • Board Certified

    Internal Medicine (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com
  • Board Certified

    Medical Oncology (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com

Editorial & leadership roles

journal and society appointments
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.